MedPath
NMPA Approval

Ozagrel Sodium for Injection

国药准字H20084146

August 5, 2020

Drug Information

注射用奥扎格雷钠

注射剂(注射用无菌粉末)

80mg(按C13H11N2NaO2计)

化学药品

August 5, 2020

Company Information

Applicant Company

Manufacturing Company

青海省西宁经济技术开发区八一东路141号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用奥扎格雷钠 - NMPA 批准文号 | MedPath